RVL Pharmaceuticals PLC (OTCPK:RVLPQ)
$ 0.0001 0 (0%) Market Cap: 11,000.00 Enterprise Value: 39.00 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 0/100

Q2 2020 Osmotica Pharmaceuticals PLC Earnings Call Transcript

Aug 11, 2020 / 08:30PM GMT
Release Date Price: $5.6 (-2.61%)
Operator

Ladies and gentlemen, thank you for standing by and welcome to the Osmotica Second Quarter 2020 Earnings Call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions)

I would now like to hand the conference over to your speaker today, Lisa Wilson, Investor Relations for Osmotica. Please go ahead.

Lisa Wilson;In;Site Communications;President

Thank you, operator.

Welcome to Osmotica Pharmaceuticals' Second Quarter 2020 Business Update Call. This is Lisa Wilson, Investor Relations for Osmotica. With me on today's call are Osmotica's Chief Executive Officer, Brian Markison; Chief Operating Officer, JD Schaub; and Chief Financial Officer, Andrew Einhorn. We are also joined by Dr. Derek Cunningham, Director of Optometry and Research from Dell Laser Consultants.

This afternoon the company issued a press release detailing financial results for the 3 months ended June 30, 2020. This press release and a webcast of this call, which also includes a

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot